# Peoples Financial Services Corp.: financial statements, quarterly

PFIS · Nasdaq · CIK 1056943 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pfis.md) · [Financials](/companies/pfis/financials.md) · [Filings](/companies/pfis/filings.md) · [Insiders](/companies/pfis/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pfis/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [17.5](/filings/0001558370-23-018552.md) | [19.8 d](/filings/0001558370-24-003373.md) | [19.7](/filings/0001558370-24-007305.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.3](/filings/0001558370-24-015698.md) | [0.6 d](/filings/0001104659-26-028106.md) | [0.5](/filings/0001558370-25-007366.md) | [0.4](/filings/0001558370-25-011043.md) | [(0.7)](/filings/0001104659-25-108874.md) | [(0.3) d](/filings/0001104659-26-028106.md) | [3.2](/filings/0001104659-26-057903.md) | [3.5](/filings/0001104659-26-092684.md) | [3.6](/filings/0001104659-25-108874.md) | [2.7 d](/filings/0001104659-26-028106.md) | [3.8](/filings/0001104659-26-057903.md) | [3.6](/filings/0001104659-26-092684.md) |
| Net income | $m | [6.7](/filings/0001558370-24-015698.md) | [3.6 d](/filings/0001104659-26-028106.md) | [3.5](/filings/0001104659-25-108874.md) | [3.3](/filings/0001104659-25-108874.md) | [(4.3)](/filings/0001104659-25-108874.md) | [6.1 d](/filings/0001104659-26-028106.md) | [15.0](/filings/0001104659-26-092684.md) | [17.0](/filings/0001104659-26-092684.md) | [15.2](/filings/0001104659-25-108874.md) | [12.0 d](/filings/0001104659-26-028106.md) | [14.7](/filings/0001104659-26-092684.md) | [14.8](/filings/0001104659-26-092684.md) |
| Diluted EPS | $ per share | [0.95](/filings/0001558370-24-015698.md) | not reported | [0.49](/filings/0001558370-25-007366.md) | [0.46](/filings/0001558370-25-011043.md) | [(0.43)](/filings/0001104659-25-108874.md) | not reported | [1.49](/filings/0001104659-26-057903.md) | [1.68](/filings/0001104659-26-092684.md) | [1.51](/filings/0001104659-25-108874.md) | not reported | [1.47](/filings/0001104659-26-057903.md) | [1.48](/filings/0001104659-26-092684.md) |
| Basic EPS | $ per share | [0.95](/filings/0001558370-24-015698.md) | not reported | [0.49](/filings/0001558370-25-007366.md) | [0.47](/filings/0001558370-25-011043.md) | [(0.43)](/filings/0001104659-25-108874.md) | not reported | [1.50](/filings/0001104659-26-057903.md) | [1.70](/filings/0001104659-26-092684.md) | [1.53](/filings/0001104659-25-108874.md) | not reported | [1.47](/filings/0001104659-26-057903.md) | [1.48](/filings/0001104659-26-092684.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [3,826](/filings/0001558370-23-018552.md) | [3,742](/filings/0001558370-25-003995.md) | [3,669](/filings/0001558370-24-007305.md) | [3,616](/filings/0001558370-24-011338.md) | [5,360](/filings/0001558370-24-015698.md) | [5,092](/filings/0001104659-26-028106.md) | [4,999](/filings/0001558370-25-007366.md) | [5,108](/filings/0001558370-25-011043.md) | [5,160](/filings/0001104659-25-108874.md) | [5,271](/filings/0001104659-26-092684.md) | [5,423](/filings/0001104659-26-057903.md) | [5,441](/filings/0001104659-26-092684.md) |
| Total liabilities | $m | [3,501](/filings/0001558370-23-018552.md) | [3,402](/filings/0001558370-25-003995.md) | [3,329](/filings/0001558370-24-007305.md) | [3,275](/filings/0001558370-24-011338.md) | [4,885](/filings/0001558370-24-015698.md) | [4,623](/filings/0001104659-26-028106.md) | [4,518](/filings/0001558370-25-007366.md) | [4,614](/filings/0001558370-25-011043.md) | [4,650](/filings/0001104659-25-108874.md) | [4,751](/filings/0001104659-26-092684.md) | [4,898](/filings/0001104659-26-057903.md) | [4,904](/filings/0001104659-26-092684.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [27.0](/filings/0001558370-23-018552.md) | [17.6](/filings/0001104659-26-028106.md) | [20.3](/filings/0001558370-24-007305.md) | [104](/filings/0001558370-24-011338.md) | [37.3](/filings/0001558370-24-015698.md) | [15.9](/filings/0001104659-26-028106.md) | [14.8](/filings/0001558370-25-007366.md) | [76.3](/filings/0001558370-25-011043.md) | [76.3](/filings/0001104659-25-108874.md) | [32.7](/filings/0001104659-26-092684.md) | [179](/filings/0001104659-26-057903.md) | [85.3](/filings/0001104659-26-092684.md) |
| Shareholders' equity | $m | [324](/filings/0001558370-24-015698.md) | [340](/filings/0001104659-26-028106.md) | [340](/filings/0001104659-25-108874.md) | [341](/filings/0001104659-25-108874.md) | [475](/filings/0001104659-25-108874.md) | [469](/filings/0001104659-26-092684.md) | [482](/filings/0001104659-26-092684.md) | [494](/filings/0001104659-26-092684.md) | [509](/filings/0001104659-25-108874.md) | [520](/filings/0001104659-26-092684.md) | [526](/filings/0001104659-26-092684.md) | [536](/filings/0001104659-26-092684.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [6.7 d](/filings/0001558370-24-015698.md) | [8.9 d](/filings/0001104659-26-028106.md) | [3.2](/filings/0001558370-25-007366.md) | [1.7 d](/filings/0001558370-25-011043.md) | [21.9 d](/filings/0001104659-25-108874.md) | [7.9 d](/filings/0001104659-26-028106.md) | [9.1](/filings/0001104659-26-057903.md) | [13.9 d](/filings/0001104659-26-092684.md) | [15.2 d](/filings/0001104659-25-108874.md) | [16.1 d](/filings/0001104659-26-028106.md) | [8.3](/filings/0001104659-26-057903.md) | [13.9 d](/filings/0001104659-26-092684.md) |
| Capital expenditure | $m | [1.2 d](/filings/0001558370-24-015698.md) | [0.2 d](/filings/0001104659-26-028106.md) | [0.2](/filings/0001558370-25-007366.md) | [0.4 d](/filings/0001558370-25-011043.md) | [4.3 d](/filings/0001104659-25-108874.md) | [(2.4) d](/filings/0001104659-26-028106.md) | [0.5](/filings/0001104659-26-057903.md) | [5.4 d](/filings/0001104659-26-092684.md) | [2.2 d](/filings/0001104659-25-108874.md) | [2.9 d](/filings/0001104659-26-028106.md) | [1.8](/filings/0001104659-26-057903.md) | [1.7 d](/filings/0001104659-26-092684.md) |
| Dividends paid | $m | [2.9 d](/filings/0001558370-24-015698.md) | [2.9 d](/filings/0001104659-26-028106.md) | [2.9](/filings/0001558370-25-007366.md) | [2.9 d](/filings/0001558370-25-011043.md) | [6.2 d](/filings/0001104659-25-108874.md) | [6.2 d](/filings/0001104659-26-028106.md) | [6.2](/filings/0001104659-26-057903.md) | [6.2 d](/filings/0001104659-26-092684.md) | [6.2 d](/filings/0001104659-25-108874.md) | [6.2 d](/filings/0001104659-26-028106.md) | [6.2](/filings/0001104659-26-057903.md) | [6.3 d](/filings/0001104659-26-092684.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [7.2](/filings/0001558370-23-018552.md) | [7.2](/filings/0001558370-24-007305.md) | [7.2](/filings/0001558370-24-011338.md) | [7.1](/filings/0001558370-24-015698.md) | [7.1](/filings/0001558370-25-007366.md) | [7.1](/filings/0001558370-25-011043.md) | [10.0](/filings/0001104659-25-108874.md) | [10.0](/filings/0001104659-26-057903.md) | [10.1](/filings/0001104659-26-092684.md) | [10.1](/filings/0001104659-25-108874.md) | [10.0](/filings/0001104659-26-057903.md) | [10.0](/filings/0001104659-26-092684.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,010,367 at 2028-08-01, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092684.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.